Dr. Ralph Hauke, MD
Claim this profileNebraska Cancer Specialists
Expert in Prostate Cancer
Studies Lung Cancer
36 reported clinical trials
74 drugs studied
About Ralph Hauke, MD
Education:
- Obtained MD (Doctor of Medicine) from the University of Nebraska Medical Center in 1986.
- Completed Residency in Internal Medicine at the University of Nebraska Medical Center in 1989.
- Finished Fellowship in Hematology/Oncology at the University of Nebraska Medical Center in 1991.
Experience:
- Currently practices as an oncologist and hematologist at Nebraska Cancer Specialists.
- Extensive training and medical education at the University of Nebraska Medical Center.
Area of expertise
1Prostate Cancer
Global LeaderStage IV
PD-L1 positive
BRCA positive
2Lung Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Ralph Hauke, MD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Ralph Hauke, MD
Clinical Trial Related2 years of experience running clinical trials · Led 36 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Ralph Hauke, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Docetaxel
- Cisplatin
- Prednisone
Breakdown of trials Ralph Hauke, MD has run
Prostate Cancer
Lung Cancer
Melanoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ralph Hauke, MD specialize in?
Ralph Hauke, MD focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Ralph Hauke, MD currently recruiting for clinical trials?
Yes, Ralph Hauke, MD is currently recruiting for 9 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Ralph Hauke, MD has studied deeply?
Yes, Ralph Hauke, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Ralph Hauke, MD?
Apply for one of the trials that Ralph Hauke, MD is conducting.
What is the office address of Ralph Hauke, MD?
The office of Ralph Hauke, MD is located at: Nebraska Cancer Specialists, Omaha, Nebraska 68114 United States. This is the address for their practice at the Nebraska Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.